These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3449146)

  • 1. Perspectives on the hemoperfusion of drugs and toxins.
    Schreiner GE
    Biomater Artif Cells Artif Organs; 1987; 15(1):305-21. PubMed ID: 3449146
    [No Abstract]   [Full Text] [Related]  

  • 2. Extracorporeal removal of drugs and poisons by hemodialysis and hemoperfusion.
    Cutler RE; Forland SC; Hammond PG; Evans JR
    Annu Rev Pharmacol Toxicol; 1987; 27():169-91. PubMed ID: 3579241
    [No Abstract]   [Full Text] [Related]  

  • 3. Dialysis and hemoperfusion in poisoning.
    Winchester JF
    Adv Ren Replace Ther; 2002 Jan; 9(1):26-30. PubMed ID: 11927904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gas chromatographic determination of drug levels for the evaluation of a combined hemoperfusion-hemodialysis treatment.
    De Waele M; Heyndrickx A; De Broe M
    J Anal Toxicol; 1982; 6(6):282-5. PubMed ID: 7162136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dialysis and hemoperfusion of poisons and drugs--update.
    Winchester JF; Gelfand MC; Knepshield JH; Schreiner GE
    Trans Am Soc Artif Intern Organs; 1977; 23():762-842. PubMed ID: 333704
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined hemoperfusion-hemodialysis in severe poisoning: kinetics of drug extraction.
    Verpooten GA; De Broe ME
    Resuscitation; 1984 Mar; 11(3-4):275-89. PubMed ID: 6326227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A comparison of the efficiency of eliminating middle-weight molecules and myoinositol from plasma during hemoperfusion and hemodialysis in cases of chronic uremia].
    Trznadel K; Kidawa Z; Walasek L; Lutz W
    Pol Tyg Lek; 1978 Feb; 33(7):257-9. PubMed ID: 758030
    [No Abstract]   [Full Text] [Related]  

  • 8. Diuresis, dialysis, and hemoperfusion. Indications and benefits.
    Pond SM
    Emerg Med Clin North Am; 1984 Feb; 2(1):29-45. PubMed ID: 6519021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effect of hemoperfusion through activated charcoal on middle molecular substances in the plasma during a long-term dialysis program].
    Mydlík M; Dzúrik R; Derzsiová K; Spustová V
    Cas Lek Cesk; 1983 Dec; 122(51):1573-6. PubMed ID: 6652672
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of hemoperfusion as an adjunct to hemodialysis.
    Trafford A; Ireland R; Evans R
    Artif Organs; 1979 Aug; 3(3):249-52. PubMed ID: 533415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of hemoperfusion and hemodialysis clearances during combined and prolonged treatment of severely poisoned patients.
    Verpooten GA; Heyndrickx A; Zachee P; De Broe ME
    Dev Toxicol Environ Sci; 1980; 8():411-4. PubMed ID: 7308040
    [No Abstract]   [Full Text] [Related]  

  • 12. Evolution of artificial organs: extracorporeal removal of drugs.
    Winchester JF
    Artif Organs; 1986 Aug; 10(4):316-23. PubMed ID: 3753258
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of drugs during various detoxification procedures for overdose and environmental exposure.
    Holazo AA; Colburn WA
    Drug Metab Rev; 1982; 13(4):715-43. PubMed ID: 7128457
    [No Abstract]   [Full Text] [Related]  

  • 14. Direct-contact (membraneless) hemoperfusion through oils.
    Evenson MA; De Vos D
    Clin Chem; 1972 Jun; 18(6):554-62. PubMed ID: 4623753
    [No Abstract]   [Full Text] [Related]  

  • 15. Gastrointestinal clearance of drugs with activated charcoal.
    Levy G
    N Engl J Med; 1982 Sep; 307(11):676-8. PubMed ID: 7110218
    [No Abstract]   [Full Text] [Related]  

  • 16. [Role of clinical pharmacokinetics in the causal treatment of acute drug poisoning].
    Lesne M
    Bull Mem Acad R Med Belg; 1981; 136(8-9):443-72. PubMed ID: 7042014
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical pharmacokinetics in the causal treatment of acute intoxications (author's transl)].
    Lesne M; Jacqmin P; Bouchat JM; Mahieu P
    Therapie; 1981; 36(5):511-23. PubMed ID: 7034287
    [No Abstract]   [Full Text] [Related]  

  • 18. A purification method by uncoated charcoal.
    Cerulli N; Politi L; D'Angelo AR; Scandurra R
    Adv Exp Med Biol; 1987; 223():193-6. PubMed ID: 3447435
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of charcoal haemoperfusion in 55 acute poisonings.
    Mydlík M; Derzsiová K; Bucek J; Horký K; Jarcuska J; Takác M
    Life Support Syst; 1983; 1 Suppl 1():53-6. PubMed ID: 6336462
    [No Abstract]   [Full Text] [Related]  

  • 20. Prediction of the efficacy of hemoperfusion and hemodialysis in severe poisoning.
    Verpooten GA; De Broe ME
    Arch Toxicol Suppl; 1982; 5():304-6. PubMed ID: 6954915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.